QS Investors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
QS Investors's HALO Position: Q2 2021 in Review
QS Investors increased its Halozyme (HALO) stake by 1.7% in Q2 2021, buying an estimated $48.7K and bringing the position to 65,000 shares worth $2.95M. The position accounts for 0.03% of the portfolio, ranked #306.
QS Investors first reported a position in HALO in Q4 2014 and has held it in 27 quarters since. The position peaked at $3.54M in Q2 2015. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.
- QS Investors held 65,000 shares of Halozyme worth $2.95M as of Q2 2021.
- QS Investors bought 1,100 Halozyme shares in Q2 2021, an estimated $48.7K.
- Halozyme made up 0.03% of QS Investors's portfolio in Q2 2021, its #306 holding.
- QS Investors first reported a position in Halozyme in Q4 2014 and has held it in 27 quarters since.
- QS Investors's Halozyme position peaked at $3.54M in Q2 2015.
- 313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.